BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 306 filers reported holding BLUEBIRD BIO INC in Q1 2018. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $1,000 | 0.0% | 32 | +45.5% | 0.00% | – |
| Q1 2021 | $1,000 | 0.0% | 22 | -12.0% | 0.00% | – |
| Q4 2020 | $1,000 | 0.0% | 25 | 0.0% | 0.00% | – |
| Q3 2020 | $1,000 | -50.0% | 25 | -37.5% | 0.00% | – |
| Q2 2020 | $2,000 | 0.0% | 40 | +185.7% | 0.00% | -100.0% |
| Q3 2018 | $2,000 | -92.3% | 14 | -90.7% | 0.00% | -92.3% |
| Q1 2018 | $26,000 | -3.7% | 150 | 0.0% | 0.01% | 0.0% |
| Q4 2017 | $27,000 | +800.0% | 150 | +226.1% | 0.01% | +550.0% |
| Q3 2016 | $3,000 | +50.0% | 46 | -19.3% | 0.00% | +100.0% |
| Q1 2016 | $2,000 | -33.3% | 57 | +72.7% | 0.00% | -50.0% |
| Q3 2015 | $3,000 | -50.0% | 33 | 0.0% | 0.00% | -50.0% |
| Q2 2015 | $6,000 | +50.0% | 33 | 0.0% | 0.00% | +100.0% |
| Q1 2015 | $4,000 | – | 33 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sessa Capital IM, L.P. | 1,834,965 | $35,066,000 | 1.72% |
| Birchview Capital, LP | 84,000 | $1,605,000 | 1.09% |
| ARMISTICE CAPITAL, LLC | 2,472,000 | $47,240,000 | 0.80% |
| EcoR1 Capital, LLC | 802,507 | $15,336,000 | 0.53% |
| Parametrica Management Ltd | 36,919 | $706,000 | 0.53% |
| Bain Capital Life Sciences Investors, LLC | 538,179 | $7,239,000 | 0.45% |
| APPLETON GROUP, LLC | 19,495 | $373,000 | 0.32% |
| MANGROVE PARTNERS IM, LLC | 175,587 | $3,355,000 | 0.30% |
| Quinn Opportunity Partners LLC | 230,100 | $4,397,000 | 0.28% |
| PDT Partners, LLC | 171,700 | $3,281,000 | 0.24% |